Researchers seek sharper MRI images in new study
NCT ID NCT01130545
First seen Jun 27, 2026 · Last updated Sep 17, 2026 · Updated 8 times
Summary
This study aims to improve how MRI scans are done by testing new imaging techniques on up to 1,000 healthy volunteers and people with cardiac risk factors. Participants will have one or more MRI scans over a few years, with some receiving a contrast dye. The goal is to refine current methods and develop better ways to capture clear images of the body.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 1,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2010
- Lead sponsor
-
A government research agency
The lead sponsor is the US National Institutes of Health.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Volunteers (maybe Volunteers, NIH employee and current NIH protocol participants)
- Ages
-
18 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
* INCLUSION CRITERIA: A. Volunteer individuals B. Lab Eligibility parameters (for contrast scans within 4 weeks of gadolinium injection): C. Creatinine below upper normal limit D. eGFR \>= 60 mL/min/1.73m2 E. Age \>= 60 or history of renal disease: test GFR within 1 week prior to contrast F. Willing to travel to the NIH for follow-up visits. G. 18 years old H. Able to understand and sign informed consent I. No MRI scan with gadolinium injection in the last 6 months under this protocol. EXCLUSION CRITERIA: A. Implanted metal clips or wires of the type which may concentrate radiofrequency fields or cause tissue damages from twisting in a Magnetic field. Examples: * Aneurysm clip, implanted neural stimulator, * Implanted cardiac pacemaker, defibrillator, or certain other implanted electrical or metallic devices, * Cochlear implant, ocular foreign body (metal shavings), * Any implanted device (pumps, infusion devices, etc.), * Shrapnel injuries, * History of metal in head or eyes or other parts of the body. B. Pregnant women C. Paralyzed hemidiaphragm D. Over 500 lbs and/or a body circumference that prevents the study subject from laying flat in the scanner E. Surgery of uncertain type F. Untreatable claustrophobia otherwise requiring anesthesia. G. Any contraindications that the Physician identifies from the subject, MRI Safety Questionnaire, and/or History and Physical. EXCLUSION FOR PARTICIPANTS FOR GADOLINIUM CONTRAST: (Inclusive of the above exclusion criteria): A. Allergy to gadolinium for scans using contrast; will be eligible for non-contrast scans. B. Acute renal failure, renal transplant, dialysis and renal failure individuals (eGFR \<60 mL/min/1.73m2 and/or clinically diagnosed). C. Individuals with a history of liver transplant or severe liver disease. D. Lactating women E. Individuals with hemoglobinopathies or severe asthma. F. Patient preference to not undergo intravenous line placement and/or receive gadolinium contrast. Contrast administration is optional and participants may still undergo a non-contrast study. G. GBCA with an MRI scan in the last 6 months. This includes scan performed with GBCA at any outside institution and / or at the clinical center .In addition, they cannot have reached their maximum of 4 GBCA imaging studies under this protocol. They will be excluded from having a contrast enhanced MRI, but will not be excluded from the protocol for non-contrast MRI studies.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiac risk factors are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New sedative candidate goes Head-to-Head with propofol in early human test
- Can a protein powder with creatine and fiber boost everyday Well-Being?
- Green tech or hidden stress? bus Drivers' hearts monitored behind the wheel
- Can a Room-Temperature dairy drink build muscle?
- New injection MWN117 tested for safety in obesity
- Shout it out: can growls and screams raise pain tolerance?